Argon laser iridoplasty in chronic angle closure glaucoma

Area of Science:

• Ophthalmology
• Glaucoma Research
• Laser Therapy

Background:

• Primary chronic angle closure glaucoma (CACG) is a condition characterized by elevated intraocular pressure (IOP).
• Medical therapy is often insufficient for controlling IOP in advanced CACG.
• Surgical intervention is frequently required for effective IOP management.

Purpose of the Study:

• To evaluate the efficacy of argon laser iridoplasty (ALI) in managing primary CACG.
• To assess the impact of ALI on intraocular pressure (IOP) and angle opening.
• To determine the potential of ALI to reduce the need for glaucoma surgery.

Main Methods:

• A cohort of 11 eyes with primary CACG and IOP > 20 mmHg despite maximal medical therapy were treated with ALI.
• Intraocular pressure (IOP) and angle status were monitored for six months post-procedure.
• Surgical intervention (trabeculectomy) was considered if medical control was not achieved.

Main Results:

• ALI successfully opened at least half of the iridocorneal angle in all treated eyes.
• A significant reduction in IOP was observed in the first week post-ALI (p < 0.002).
• At six months, 64% of eyes achieved IOP control with ALI, while 36% required trabeculectomy.

Conclusions:

• Argon laser iridoplasty is an effective procedure for widening the anterior chamber angle in CACG.
• ALI can significantly lower IOP and may serve as a valuable alternative to surgery in a majority of CACG patients.
• ALI offers a potential six-month delay in surgical intervention for many individuals with primary CACG.